findmyKOL

Kenneth Nahum, DO

Basic profile

Hackensack University Medical Center

ORCIDNone on fileNPI
RegionHowell, NJ · NortheastSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Kenneth Nahum is an Oncology physician affiliated with Hackensack University Medical Center. OpenAlex indexes 16 publications with 846 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
16publications

Distinct works indexed by OpenAlex.

846citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
44companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

4632 Route 9 S
Howell, NJ 077313319

Telephone

732-367-1535

Registry record last updated 11 Jul 2008.

View the NPPES registry record

Industry payments

44 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Blood & clotting

    43.6%
    Erythropoiesis-stimulating Agent40.6%
    Darbepoetin alfa100%
    Part B, office-administered34 patients
    Iron, parenteral preparations2.9%
    Ferric derisomaltose100%
    Part B, office-administered30 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    23.8%
    Substance P/Neurokinin-1 Receptor Antagonist19.5%
    Aprepitant100%
    Part B, office-administered41 patients
    Serotonin-3 Receptor Antagonist4.2%
    Ondansetron hydrochloride51%Palonosetron hcl48%Ondansetron Hcl2%Ondansetron Odt0%
    Part D + Part B<11 patients

    + 5 more classes in this area

  • Cancer & immunology

    15%
    PD-1 inhibitor14.3%
    Pembrolizumab100%
    Part B, office-administered23 patients
    Platinum-based Drug0.3%
    Carboplatin100%
    Part B, office-administered17 patients

    + 11 more classes in this area

Where care is delivered (Part B)0.1% facility · 99.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”